{"id":187,"date":"2019-02-12T16:18:17","date_gmt":"2019-02-12T16:18:17","guid":{"rendered":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/wenthur-lab\/?p=187"},"modified":"2025-06-13T16:21:05","modified_gmt":"2025-06-13T16:21:05","slug":"ghrelin-receptor-influence-on-cocaine-reward-is-not-directly-dependent-on-peripheral-acyl-ghrelin","status":"publish","type":"post","link":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/2019\/02\/12\/ghrelin-receptor-influence-on-cocaine-reward-is-not-directly-dependent-on-peripheral-acyl-ghrelin\/","title":{"rendered":"Ghrelin Receptor Influence on Cocaine Reward is Not Directly Dependent on Peripheral Acyl-Ghrelin"},"content":{"rendered":"

Abstract<\/h2>\r\n
\r\n\r\nThe peptide hormone acyl-ghrelin and its receptor, GHSR1a<\/sub>, represent intriguing therapeutic targets due to their actions in metabolic homeostasis and reward activity. However, this pleotropic activity makes it difficult to intervene in this system without inducing unwanted effects. Thus, it is desirable to identify passive and active regulatory mechanisms that allow differentiation between functional domains. Anatomical restriction by the blood brain barrier represents one major passive regulatory mechanism. However, it is likely that the ghrelin system is subject to additional passive mechanisms that promote independent regulation of orexigenic behavior and reward processing. By applying acyl-ghrelin sequestering antibodies, it was determined that peripheral sequestration of acyl-ghrelin is sufficient to blunt weight gain, but not cocaine rewarding effects. However, both weight gain and reward-associated behaviors were shown to be blocked by direct antagonism of GHSR1a<\/sub>.\r\n\r\nOverall, these data indicate that GHSR1a<\/sub>\u00a0effects on reward are independent from peripheral acyl-ghrelin binding, whereas centrally-mediated alteration of energy storage requires peripheral acyl-ghrelin binding. This demonstration of variable ligand-dependence amongst functionally-distinct GHSR1a<\/sub>\u00a0populations is used to generate a regulatory model for functional manipulation of specific effects when attempting to therapeutically target the ghrelin system.\r\n

Funding Source<\/h2>\r\n
\r\n\r\nWe thank the NIH for support through F32DA043323 (CJW) and Contract HHSN2757015000061 (KDJ). LFV is supported by the NIDA IRP. LL is supported by the NIAAA and NIDA IRPs.\r\n

Cited by<\/h2>\r\nThis article is cited by 9 publications\r\n
    \r\n \t
  1. \r\n
    Richardson, R. S., Sulima, A., Rice, K. C., Kucharczk, J. A., Janda, K. D., Nisbett, K. E., Koob, G. F., Vendruscolo, L. F., & Leggio, L. (2023). Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice.\u00a0Neuropharmacology<\/i>,\u00a0238<\/i>, 109643.\u00a0https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109643<\/a><\/div><\/li>\r\n \t
  2. \r\n
    Merritt, C. R., Garcia, E. J., Brehm, V. D., Fox, R. G., Moeller, F. G., Anastasio, N. C., & Cunningham, K. A. (2023). Ghrelin receptor antagonist JMV2959 blunts cocaine and oxycodone drug-seeking, but not self-administration, in male rats.\u00a0Frontiers in pharmacology<\/i>,\u00a014<\/i>, 1268366.\u00a0https:\/\/doi.org\/10.3389\/fphar.2023.1268366<\/a><\/div><\/li>\r\n \t
  3. \r\n
    Jerlhag E. (2023). Animal studies reveal that the ghrelin pathway regulates alcohol-mediated responses.\u00a0Frontiers in psychiatry<\/i>,\u00a014<\/i>, 1050973.\u00a0https:\/\/doi.org\/10.3389\/fpsyt.2023.1050973<\/a><\/div><\/li>\r\n \t
  4. \r\n
    Navarro, G., Rea, W., Quiroz, C., Moreno, E., Gomez, D., Wenthur, C. J., Casad\u00f3, V., Leggio, L., Hearing, M. C., & Ferr\u00e9, S. (2022). Complexes of Ghrelin GHS-R1a, GHS-R1b, and Dopamine D1 Receptors Localized in the Ventral Tegmental Area as Main Mediators of the Dopaminergic Effects of Ghrelin.\u00a0The Journal of neuroscience : the official journal of the Society for Neuroscience<\/i>,\u00a042<\/i>(6), 940\u2013953.\u00a0https:\/\/doi.org\/10.1523\/JNEUROSCI.1151-21.2021<\/a><\/div><\/li>\r\n \t
  5. \r\n
    Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & \u0160lamberov\u00e1, R. (2022). The Role of Ghrelin\/GHS-R1A Signaling in Nonalcohol Drug Addictions.\u00a0International journal of molecular sciences<\/i>,\u00a023<\/i>(2), 761.\u00a0https:\/\/doi.org\/10.3390\/ijms23020761<\/a><\/div><\/li>\r\n \t
  6. \r\n
    You, Z. B., Galaj, E., Al\u00e9n, F., Wang, B., Bi, G. H., Moore, A. R., Buck, T., Crissman, M., Pari, S., Xi, Z. X., Leggio, L., Wise, R. A., & Gardner, E. L. (2021). Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral \u03b21 receptors.\u00a0Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology<\/i>, 10.1038\/s41386-021-01249-2. Advance online publication.\u00a0https:\/\/doi.org\/10.1038\/s41386-021-01249-2<\/a><\/div><\/li>\r\n \t
  7. \r\n
    Shevchouk, O. T., Tufvesson-Alm, M., & Jerlhag, E. (2021). An Overview of Appetite-Regulatory Peptides in Addiction Processes; From Bench to Bed Side.\u00a0Frontiers in neuroscience<\/i>,\u00a015<\/i>, 774050.\u00a0https:\/\/doi.org\/10.3389\/fnins.2021.774050<\/a><\/div><\/li>\r\n \t
  8. \r\n
    Davis, T. R., Pierce, M. R., Novak, S. X., & Hougland, J. L. (2021). Ghrelin octanoylation by ghrelin\u00a0O<\/i>-acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling.\u00a0Open biology<\/i>,\u00a011<\/i>(7), 210080.\u00a0https:\/\/doi.org\/10.1098\/rsob.210080<\/a><\/div><\/li>\r\n \t
  9. \r\n
    Abizaid, A., & Hougland, J. L. (2020). Ghrelin Signaling: GOAT and GHS-R1a Take a LEAP in Complexity.\u00a0Trends in endocrinology and metabolism: TEM<\/i>,\u00a031<\/i>(2), 107\u2013117.\u00a0https:\/\/doi.org\/10.1016\/j.tem.2019.09.006<\/a><\/div><\/li>\r\n<\/ol>\r\n<\/div>\r\n<\/div>","protected":false},"excerpt":{"rendered":"Abstract The peptide hormone acyl-ghrelin and its receptor, GHSR1a, represent intriguing therapeutic targets due to their actions in metabolic homeostasis and reward activity. However, this pleotropic activity makes it difficult to intervene in this system …","protected":false},"author":7,"featured_media":188,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-feature-publications"],"acf":[],"_links":{"self":[{"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/posts\/187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/comments?post=187"}],"version-history":[{"count":1,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/posts\/187\/revisions"}],"predecessor-version":[{"id":189,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/posts\/187\/revisions\/189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/media\/188"}],"wp:attachment":[{"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/media?parent=187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/categories?post=187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/wenthur-lab\/wp-json\/wp\/v2\/tags?post=187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}